453 related articles for article (PubMed ID: 15737307)
1. [The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].
Ruiz Hernández G; Romero de Avila Y Avalos C; Carreras Delgado JL
Med Clin (Barc); 2005 Feb; 124(6):229-36. PubMed ID: 15737307
[TBL] [Abstract][Full Text] [Related]
2. [Fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography in colorectal cancer].
Tang G; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Feb; 22(1):193-6, 201. PubMed ID: 15762148
[TBL] [Abstract][Full Text] [Related]
3. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography: clinical applications in oncology. Part 1.
Kumar R; Nadig MR; Chauhan A
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of FDG-PET in oncology].
Sasaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
[TBL] [Abstract][Full Text] [Related]
9. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
[TBL] [Abstract][Full Text] [Related]
10. [18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.
Kaanders JHAM; Bussink J; Aarntzen EHJG; Braam P; Rütten H; van der Maazen RWM; Verheij M; van den Bosch S
Semin Radiat Oncol; 2023 Jul; 33(3):287-297. PubMed ID: 37331783
[TBL] [Abstract][Full Text] [Related]
11. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of positron emission tomography-computed tomography in oncology.
Kumar R; Halanaik D; Malhotra A
Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
[TBL] [Abstract][Full Text] [Related]
13. 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases.
Subesinghe M; Bhuva S; Arumalla N; Cope A; D'Cruz D; Subesinghe S
Rheumatology (Oxford); 2022 May; 61(5):1769-1782. PubMed ID: 34463703
[TBL] [Abstract][Full Text] [Related]
14. Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose.
Giorgetti A; Volterrani D; Mariani G
Radiol Med; 2002 Apr; 103(4):293-318. PubMed ID: 12107381
[TBL] [Abstract][Full Text] [Related]
15. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
Kubota K
Ann Nucl Med; 2001 Dec; 15(6):471-86. PubMed ID: 11831394
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms.
Sarda-Mantel L; Alsac JM; Boisgard R; Hervatin F; Montravers F; Tavitian B; Michel JB; Le Guludec D
J Vasc Surg; 2012 Sep; 56(3):765-73. PubMed ID: 22726755
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M
Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214
[TBL] [Abstract][Full Text] [Related]
18. The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology.
Vansteenkiste JF; Stroobants SG
Eur Respir J; 2001 Apr; 17(4):802-20. PubMed ID: 11401078
[TBL] [Abstract][Full Text] [Related]
19. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET scanning in the diagnosis of gastrointestinal cancers.
van Kouwen MC; Oyen WJ; Nagengast FM; Jansen JB; Drenth JP
Scand J Gastroenterol Suppl; 2004; (241):85-92. PubMed ID: 15696855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
